<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments for BioHealth Investor - Biotech and Medical Business Blog</title>
	<atom:link href="http://www.biohealthinvestor.com/comments/feed" rel="self" type="application/rss+xml" />
	<link>http://www.biohealthinvestor.com</link>
	<description></description>
	<pubDate>Thu, 28 Aug 2008 01:58:31 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.5.1</generator>
		<item>
		<title>Comment on Are NovaDel and Pfizer Collaborating on a Viagra Spray? by Biotech Implosion: Favrille (FVRL) &#124; Biotech Stocks Blog</title>
		<link>http://www.biohealthinvestor.com/2007/02/are-novadel-and-pfizer-collaborating-on-a-viagra-spray.html#comment-26</link>
		<dc:creator>Biotech Implosion: Favrille (FVRL) &#124; Biotech Stocks Blog</dc:creator>
		<pubDate>Tue, 27 May 2008 19:28:26 +0000</pubDate>
		<guid isPermaLink="false">http://www.biohealthinvestor.com/2007/02/are-novadel-and-pfizer-collaborating-on-a-viagra-spray.html#comment-26</guid>
		<description>[...] on the market, and has strong co-agreements in North America and Europe, including rumors of a potential oral spray formulation of Viagra in collaboration with [...]</description>
		<content:encoded><![CDATA[<p>[...] on the market, and has strong co-agreements in North America and Europe, including rumors of a potential oral spray formulation of Viagra in collaboration with [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
